Animalcare Group (ANCR)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 227.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 236.00
  • 52 Week Low: 166.40
  • Currency: UK Pounds
  • Shares Issued: 60.11m
  • Volume: 17,526
  • Market Cap: £136.44m

Animalcare Group posts 'very strong' first half

By Josh White

Date: Wednesday 15 Feb 2017

LONDON (ShareCast) - (ShareCast News) - Veterinary medicine supplier Animalcare Group announced its interim results for the six months to 31 December on Wednesday, with the board describing a "very strong" first half for the group, ahead of expectations.
The AIM-traded company reported revenue of £7.97m, a 12% improvement, with underlying operating profit up 22.6% to £1.9m and underlying EBITDA ahead 26% at £2.12m.

Basic underlying earnings per share were 25.8% firmer at 7.8p.

On a reported basis, operating profit was still up 23.5% at £1.85m, and basic earnings per share were 23% higher at 7.5p.

At period end, Animalcare had cash and cash equivalents of £7.01m - 15% higher than at the same time last year.

The board declared an interim dividend of 2p per share, up from 1.8p a year ago.

"The business continued to perform strongly during the first six months of its financial year with sales up by 12% to £8.0m," said Animalcare chairman James Lambert.

"Given the strong start to the current financial year, and the expected launch of more new pharmaceutical products in the second half, your board remains confident about the group's prospects for the full year and beyond."

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

ANCR Market Data

Currency UK Pounds
Share Price 227.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 236.00
52 Week Low 166.40
Volume 17,526
Shares Issued 60.11m
Market Cap £136.44m

ANCR Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
76.91% below the market average76.91% below the market average76.91% below the market average76.91% below the market average76.91% below the market average
1.96% below the sector average1.96% below the sector average1.96% below the sector average1.96% below the sector average1.96% below the sector average
Price Trend
47.72% above the market average47.72% above the market average47.72% above the market average47.72% above the market average47.72% above the market average
67.27% above the sector average67.27% above the sector average67.27% above the sector average67.27% above the sector average67.27% above the sector average
Income
78.11% below the market average78.11% below the market average78.11% below the market average78.11% below the market average78.11% below the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average
Growth
24.88% below the market average24.88% below the market average24.88% below the market average24.88% below the market average24.88% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average

What The Brokers Say

Strong Buy 0
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

ANCR Dividends

  Latest Previous
  Final Interim
Ex-Div 20-Jun-24 19-Oct-23
Paid 19-Jul-24 17-Nov-23
Amount 3.00p 2.00p

Trades for 08-May-2024

Time Volume / Share Price
10:14 206 @ 226.50p
09:42 1,250 @ 232.00p
09:42 5,000 @ 227.00p
09:28 9,092 @ 225.88p
09:27 1,266 @ 225.88p

ANCR Key Personnel

CFO Chris Brewster
CEO Jenny Winter

Top of Page